165 related articles for article (PubMed ID: 31620453)
21. The changing global distribution and prevalence of canine transmissible venereal tumour.
Strakova A; Murchison EP
BMC Vet Res; 2014 Sep; 10():168. PubMed ID: 25186078
[TBL] [Abstract][Full Text] [Related]
22. Canine transmissible venereal tumor cell depletion of B lymphocytes: molecule(s) specifically toxic for B cells.
Liao KW; Hung SW; Hsiao YW; Bennett M; Chu RM
Vet Immunol Immunopathol; 2003 May; 92(3-4):149-62. PubMed ID: 12730015
[TBL] [Abstract][Full Text] [Related]
23. Cell-based polymerase chain reaction for canine transmissible venereal tumor (CTVT) diagnosis.
Setthawongsin C; Techangamsuwan S; Tangkawattana S; Rungsipipat A
J Vet Med Sci; 2016 Aug; 78(7):1167-73. PubMed ID: 27075116
[TBL] [Abstract][Full Text] [Related]
24. A retrospective study of canine transmissible venereal tumour in Grenada, West Indies.
Schectman SJ; Khanam A; Walters MND; Kirwan E; Sylvester WR; Khan FA
Vet Med Sci; 2022 May; 8(3):1008-1012. PubMed ID: 35238497
[TBL] [Abstract][Full Text] [Related]
25. Heat shock proteins in canine transmissible venereal tumor.
Chu RM; Sun TJ; Yang HY; Wang DG; Liao KW; Chuang TF; Lin CH; Lee WC
Vet Immunol Immunopathol; 2001 Sep; 82(1-2):9-21. PubMed ID: 11557291
[TBL] [Abstract][Full Text] [Related]
26. Canine transmissible venereal tumour: a morphological and immunohistochemical study of 11 tumours in growth phase and during regression after chemotherapy.
Gonzalez CM; Griffey SM; Naydan DK; Flores E; Cepeda R; Cattaneo G; Madewell BR
J Comp Pathol; 2000 May; 122(4):241-8. PubMed ID: 10805977
[TBL] [Abstract][Full Text] [Related]
27. Does the tumour microenvironment alter tumorigenesis and clinical response in transmissible venereal tumour in dogs?
Ballestero Fêo H; Montoya Flórez L; Yamatogi RS; Prado Duzanski A; Araújo JP; Oliveira RA; Rocha NS
Vet Comp Oncol; 2018 Sep; 16(3):370-378. PubMed ID: 29508538
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a genetic assay for canine transmissible venereal tumour diagnosis in Brazil.
Castro KF; Strakova A; Tinucci-Costa M; Murchison EP
Vet Comp Oncol; 2017 Jun; 15(2):615-618. PubMed ID: 27135875
[TBL] [Abstract][Full Text] [Related]
29. Identification of canine transmissible venereal tumor cells using in situ polymerase chain reaction and the stable sequence of the long interspersed nuclear element.
Liao KW; Lin ZY; Pao HN; Kam SY; Wang FI; Chu RM
J Vet Diagn Invest; 2003 Sep; 15(5):399-406. PubMed ID: 14535538
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of a Canine Transmissible Venereal Tumour Cell Line with Tumour Immunity Capacity but Without Tumorigenic Property.
Zayas YR; Molina MAF; Guerra RT; Padilla CR
J Vet Res; 2019 Jun; 63(2):225-233. PubMed ID: 31276062
[TBL] [Abstract][Full Text] [Related]
31. Sex disparity in oronasal presentations of canine transmissible venereal tumour.
Strakova A; Baez-Ortega A; Wang J; Murchison EP
Vet Rec; 2022 Sep; 191(5):e1794. PubMed ID: 35781651
[TBL] [Abstract][Full Text] [Related]
32. TP53 Polymorphisms allow for genetic sub-grouping of the canine transmissible venereal tumor.
Sánchez-Servín A; Martínez S; Córdova-Alarcon E; Fajardo R
J Vet Sci; 2009 Dec; 10(4):353-5. PubMed ID: 19934603
[TBL] [Abstract][Full Text] [Related]
33. Proliferation characteristics of canine transmissible venereal tumor.
Chu RM; Lin CY; Liu CC; Yang SY; Hsiao YW; Hung SW; Pao HN; Liao KW
Anticancer Res; 2001; 21(6A):4017-24. PubMed ID: 11911286
[TBL] [Abstract][Full Text] [Related]
34. Identification of mitochondrial DNA transfer in canine transmissible venereal tumours obtained from dogs in Mexico.
Bautista-Gómez L; Martínez-Castañeda S
Mitochondrial DNA A DNA Mapp Seq Anal; 2017 Sep; 28(5):645-649. PubMed ID: 27159723
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of chemokine ligand 7 is associated with the progression of canine transmissible venereal tumor.
Chiang HC; Wang YS; Chou CH; Liao AT; Chu RM; Lin CS
BMC Vet Res; 2012 Nov; 8():216. PubMed ID: 23136963
[TBL] [Abstract][Full Text] [Related]
36. Extensive conservation of genomic imbalances in canine transmissible venereal tumors (CTVT) detected by microarray-based CGH analysis.
Thomas R; Rebbeck C; Leroi AM; Burt A; Breen M
Chromosome Res; 2009; 17(7):927-34. PubMed ID: 19798471
[TBL] [Abstract][Full Text] [Related]
37. Molecular Signatures of Regression of the Canine Transmissible Venereal Tumor.
Frampton D; Schwenzer H; Marino G; Butcher LM; Pollara G; Kriston-Vizi J; Venturini C; Austin R; de Castro KF; Ketteler R; Chain B; Goldstein RA; Weiss RA; Beck S; Fassati A
Cancer Cell; 2018 Apr; 33(4):620-633.e6. PubMed ID: 29634949
[TBL] [Abstract][Full Text] [Related]
38. What a dog transmissible tumor can teach us about cancer regression.
Fassati A
Mol Cell Oncol; 2018; 5(4):e1472059. PubMed ID: 30250922
[TBL] [Abstract][Full Text] [Related]
39. Use of a murine xenograft model for canine transmissible venereal tumor.
Harmelin A; Pinthus JH; Katzir N; Kapon A; Volcani Y; Amariglio EN; Rehavi G
Am J Vet Res; 2001 Jun; 62(6):907-11. PubMed ID: 11400849
[TBL] [Abstract][Full Text] [Related]
40. Canine transmissible venereal tumour: a review.
Ganguly B; Das U; Das AK
Vet Comp Oncol; 2016 Mar; 14(1):1-12. PubMed ID: 23981098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
